Employees at Trulieve North Shore Medical Cannabis Dispensary Join UFCW 1776
PITTSBURGH, Sept. 2, 2022 /PRNewswire/ -- UFCW Local 1776 President Wendell Young IV announced today that the workers at the Trulieve North Shore medical cannabis dispensary have voted to join Local 1776.
"I want to congratulate these workers for their hard work and commitment throughout this process," Young said. "Now, we move to the bargaining table. We look forward to securing a contract that delivers fair wages, strong benefits and a safe workplace."
UFCW 1776 now represents approximately 600 cannabis workers across the state.
"We are the union for cannabis workers," Young said. "We worked hard to help secure legislation that opened the state to medical cannabis, and we will continue working for our members and all cannabis workers across Pennsylvania."
Young noted that the Local has recently organized a total of 3 dispensaries, as well as workers at Coffee Tree Roasters in recent months.
"Our western division, which includes workers in Pennsylvania, Ohio and West Virginia keeps growing as we add more members at more worksites," Young said. "We represent 35,000 workers in cannabis, retail, manufacturing, healthcare, gaming, and manufacturing, among others. Our reach across so many sectors is one of our core strengths."
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period.
The...
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...
